top of page

The right dose for every patient, every time

Personalized dosimetry for healthcare

Why Dose Matters, Every Time.

The Dosisphere-01 clinical trial for personalized theranostics helped improve life expectancy by 150% and increased the number of patients who could be treated by potentially curative surgery by 800%. The trial results indicated that it was deemed unethical to continue. 

Read more about the trial. We see the power of personalized dosimetry and we see it as our mission to make it available to all who need it.

For patient care

TeleDaaS helps your hospital to adhere to the highest standards of care, informed by the latest research in dosimetry.

Dosimetry for Y90 Trials

Accelerate your clinical trials and market entry with a bespoke Y90 service.

Billing support

With 97% of sites potentially underbilling, TeleDaaS provides comprehensive, high-level documentation that ensures a profitably billable service for its customers.

Integration is simple

As 80% of sites are already connected to the Nuance PowerShare network, TeleDaaS seamlessly integrates with your IT infrastructure, eliminating on-premise complexities and ensuring scalable systems as research advances.

ABOUT OUR COMPANY

TeleDaaS is a pioneering medical practice providing Dosimetry-as-a-Service from the Bench to the Bedside

Dose matters, and TeleDaaS envisions a future where every physician, hospital, and clinical trial, no matter the scale or location, can access the life-saving power of advanced dosimetry so that every patient can receive the right dose, every time.

26.6

Months median OS for large tumor HCC patients

800%

Increase in patients that could be downstaged to curative intent surgery

150%

Increased life expectancy in Dosisphere-01 trial

Happy patient with red hair

The Right Dose, Faster

Elevate patient care with our advanced dosimetry support, revolutionize radiotherapy for improved outcomes, and empower your team to transform healthcare with us.

Faded colored background
Faded green background

Speak to us

Our Technology Partners

bottom of page